Strategies for Oligonucleotide Drug Delivery and Detection

Live Webinar from Rockland Immunochemicals

Rockland Immunochemicals is a global biotechnology company manufacturing leading-edge tools for basic, applied, and clinical research in functional genomics, gene therapy, and drug discovery markets. Rockland's high-quality antibodies, reagents, services, and expertise have fueled over two generations of scientific advances and are ready to drive the next generation of discovery and development.

Join Rockland's upcoming webinar on oligonucleotide drug delivery.

Live Webinar: Strategies for Oligonucleotide Drug Delivery and Detection

Join this webinar to hear from leading experts, Aimee L. Edinger, VMD/PhD and Carl A. Ascoli, PhD, who will discuss cutting-edge advancements in the field of oligonucleotide drug delivery and detection. Learn how to overcome the hurdle of inefficient endosomal escape for oligonucleotide therapeutics with an approach that uses a synthetic sphingolipid analog to enhance the activity of antisense oligonucleotides and small interfering RNAs without causing endosomal permeability. In addition, you'll be introduced to a revolutionary panel of universal detection reagents designed to detect specific chemical modifications for the collection of ADME analytical data.

Key topics include:

Inhibition of endocytic recycling and lysosomal fusion
Methods to enhance the activity of antisense oligonucleotides and small interfering RNAs by up to 100x
Challenges that hinder oligonucleotide therapeutic drug development
Analytical tools for assessing drug performance and safety